Home Physical Sciences The crystal structure of (5-methyl-1,2,4-oxadiazol-3-yl)ferrocene, C13H12FeN2O
Article Open Access

The crystal structure of (5-methyl-1,2,4-oxadiazol-3-yl)ferrocene, C13H12FeN2O

  • Karel Škoch , Ivana Císařová and Petr Štěpnička EMAIL logo
Published/Copyright: May 31, 2017
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Zeitschrift für Kristallographie - New Crystal Structures
From the journal Zeitschrift für Kristallographie - New Crystal Structures Volume 232 Issue 4

Abstract

C13H12FeN2O, monoclinic, P21/n (no. 14), a = 5.9035(2) Å, b = 20.7111(6) Å, c = 9.1403(3) Å, β = 90.0762(16)°, V = 1117.57(6) Å3, Z = 4, Rgt(F) = 0.0282, wRref(F2) = 0.0656, T = 150(2) K.

CCDC no.:: 1548995

The crystal structure is shown in the figure. Table 1 contains measurement conditions. Table 2 lists the atoms along with their coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Orange bar
Size:0.68 × 0.14 × 0.12 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:13.3 cm−1
Diffractometer, scan mode:Bruker APEXII CCD, φ and ω
2θmax, completeness:54.8°, 99%
N(hkl)measured, N(hkl)unique, Rint:8213, 2542, 0.023
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2190
N(param)refined:155
Programs:SHELX [1], Bruker [2], [3], [4], Platon [5]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Fe0.98415(4)0.160763(11)0.13905(3)0.01745(9)
C11.0151(3)0.17589(8)0.35737(18)0.0180(3)
C21.2316(3)0.18226(9)0.28822(19)0.0208(4)
H21.36320.15750.30910.025*
C31.2134(3)0.23242(9)0.1825(2)0.0243(4)
H31.33120.24680.11980.029*
C40.9891(3)0.25736(9)0.1866(2)0.0237(4)
H40.93160.29140.12750.028*
C50.8658(3)0.22260(8)0.29448(19)0.0204(4)
H50.71170.22920.32010.025*
C60.8829(4)0.06782(9)0.1095(2)0.0329(5)
H60.86690.03630.18420.039*
C71.0767(4)0.07920(11)0.0292(3)0.0417(6)
H71.21600.05670.03960.050*
C81.0356(6)0.12834(13)−0.0680(3)0.0570(8)
H81.14140.1457−0.13570.068*
C90.8129(6)0.14828(11)−0.0505(3)0.0623(10)
H90.73910.1814−0.10430.075*
C100.7148(4)0.11026(12)0.0626(3)0.0433(6)
H100.56440.11320.09890.052*
O110.9829(2)0.05233(6)0.62557(14)0.0247(3)
N121.1115(3)0.09436(8)0.53576(17)0.0254(4)
C130.9566(3)0.12731(8)0.46631(18)0.0167(3)
N140.7366(2)0.11164(7)0.50355(16)0.0195(3)
C150.7643(3)0.06643(8)0.59945(19)0.0189(4)
C160.5931(3)0.02923(10)0.6823(2)0.0269(4)
H16A0.44120.04450.65630.040*
H16B0.61820.03520.78740.040*
H16C0.6066−0.01670.65790.040*

Source of material

Under an argon atmosphere, a solution of sodium ethoxide freshly prepared by dissolving sodium metal (230 mg, 10 mmol) in absolute ethanol (10 mL) was added to solid hydroxylamine hydrochloride (690 mg, 10 mmol). The formed precipitate (NaCl) was filtered off and the clear filtrate containing NH2OH was added to a suspension of cyanoferrocene (422 mg, 2.0 mmol) [6] in absolute ethanol (5 mL). The resultant mixture was heated under reflux for 4 h and then concentrated to ca. 4 mL by evaporation under vacuum. The residue was partitioned between ethyl acetate and 0.3 M aqueous HCl (30 mL each). The orange organic phase was separated, dried over MgSO4 and evaporated, leaving a solid residue, which was purified by chromatography on a silica gel column with ethyl acetate–hexane mixture (3:1) as the eluent. Unreacted cyanoferrocene (101 mg, 24%) was eluted first, followed by the title compound (139 mg, 26%) and, finally, ferrocenecarboxamide (137 mg, 28%).

Characterization data for the title compound. 1H NMR (399.95 MHz, CDCl3): δ 2.62 (s, 3 H, CH3), 4.15 (s, 5 H, C5H5), 4.43 and 4.89 (2 × virtual t, J = 1.7 Hz, 2 H, C5H4). 13C{1H} NMR (100.58 MHz, CDCl3): δ 12.35 (CH3), 68.20 (CH of C5H4), 69.83 (C5H5), 69.97 (Cipso of C5H4), 70.39 (CH of C5H4), 170.14 and 175.82 (2 × Cipso of oxadiazole). ESI MS+:m/z 268 (M+), 291 ([M + Na]+). Single-crystals were grown from hot n-heptane.

Experimental details

Hydrogen atoms were included in their calculated positions as refined as riding atoms (AFIX 43 and 137 for the aromatic and CH3 hydrogens, respectively, in the SHELXL-97 program [1]). The Uiso of the hydrogen atoms were constrained to a multiple of Ueq of their bonding carbon atoms (1.2-times for the aromatic CH and 1.5-times for the methyl protons).

Discussion

(5-Methyl-1,2,4-oxadiazol-3-yl)ferrocene was isolated serendipitously during an attempted preparation of ferrocenecarboxamide oxime by a modified literature procedure [7]. It appears likely that in our hands the originally targeted compound underwent an acid-catalyzed condensation with ethyl acetate used during the work-up to afford the title compound. Previously, this oxadiazole was obtained by the reaction of (ferrocenylmethyl)trimethylammonium iodide with sodium nitrite in refluxing acetonitrile [8].

The title compound crystallizes with one molecule per asymmetric unit. Its structure comprises a regular ferrocene moiety showing similar Fe—C distances (2.021(3)–2.0475(19) Å) and, consequently, practically negligible tilting of the cyclopentadienyl rings (dihedral angle: 1.31(13)°) that assume an approximate eclipsed conformation. Carbon atoms in the unsubstituted cyclopentadienyl ring exhibit large displacement parameters which, however, corresponds with a low barrier of the rotation of the cyclopentadienyl rings in ferrocene [9] and also with an absence of intermolecular interactions that could possibly control molecular conformation in the solid state.

The 1,2,4-oxadiazole moiety in the structure appears rotated with respect to its bonding cyclopentadienyl ring C(1—5) by 15.23(10)° but otherwise remains planar (the maximum deviation of the ring-forming atoms from the mean plane does not exceed 0.005 Å). The formal double bonds in the oxadiazole ring N12—C13 (1.305(2) Å) and N14—C15 (1.293(2) Å) are considerably shorter than the three remaining bonds [O11—N12 1.418(2) Å, C13—N14 1.382(2) Å, and C15—O11 1.344(2) Å], which in turn suggests a partly localized character of the oxadiazole moiety. Furthermore, the in-ring angles are all near the value expected for a regular pentagon (108°). Yet, they can be divided into two distinct groups: three angles at the heteroatoms that are more acute than the ideal value [C13—N14—C15 102.65(13)° < O11—N12—C13 103.14(15)° < N12—O11—C15 106.17(13)°], and two more opened angles associated with the carbon atoms [O11—C15—N14 113.47(15)° ¡ N12—C13—N14 114.56(15)°]. Similar features can be found in the molecular structures of the related compounds such as 5-methyl-3-(4-nitrophenyl)-1,2,4-oxadiazole [10], 3-tert-butyl-5-(4-nitrophenyl)-1,2,4-oxadiazole and 5-(4-aminophenyl)-3-tert-butyl-1,2,4-oxadiazole [11], and 5-chloromethyl-3-(4-methylphenyl)-1,2,4-oxadiazole [12].

The C1–C13 bond connecting the two molecular parts is rather short (1.457(2) Å), suggesting that the conjugation of the ferrocene unit with the attached heterocyclic moiety is not disrupted. This distance is shorter than that in ferrocencarboxamide (1.483(2) and 1.491(2) Å for two different polymorphs) [13] but compares well with the value determined for ferrocenecarboxylic acid (1.462(2) Å at 173 K) [14].

Acknowledgement

The results reported in this paper were obtained with financial support from the Czech Science Foundation (project no. 13-08890S).

References

1 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar

2 Bruker: SADABS, version 2012/1. Bruker AXS Inc., Madison, Wisconsin, USA, (2012).Search in Google Scholar

3 Bruker: APEX2 Bruker Instrument Service, version 2012.12.0.3, Bruker AXS Inc., Madison, Wisconsin, USA, (2012).Search in Google Scholar

4 Bruker: SAINT, version 8.23B. Bruker AXS Inc., Madison, Wisconsin, USA, (2013).Search in Google Scholar

5 Spek, A. L.: Single-crystal structure validation with the program PLATON. J. Appl. Crystallogr. 36 (2003) 7–13.10.1107/S0021889802022112Search in Google Scholar

6 Kivrak, A.; Zora, M.: Efficient one-pot synthesis of cyanoferrocene from ferrocenecarboxaldehyde using NH2OH⋅HCl/KI/ZnO/CH3CN system. J. Organomet. Chem. 692 (2007) 2346–2349.10.1016/j.jorganchem.2007.02.002Search in Google Scholar

7 Ryabov, A. D.; Kazankov, G. M.; Panyashkina, I. M.; Grozovsky, O. V.; Dyachenko, O. G.; Polyakov, V. A.; Kuz’mina, L. G.: Cycloplatination of aryl and ferrocenyl oximes by cis-[PtCl2(OSMe2)2] affording expected Pt(II) and unexpected Pt(IV) products. J. Chem. Soc., Dalton Trans. (1997) 4385–4391.10.1039/a702281fSearch in Google Scholar

8 Kondo, T.; Yamamoto, K.; Danda, H.; Kumada, M.: A novel reaction of (ferrocenylmethyl)trimethylammonium iodide. One step synthesis of 3-ferrocenyl-5-alkyl-1,2,4-oxadiazoles. J. Organomet. Chem. 61 (1973) 361–364.10.1016/S0022-328X(00)86566-3Search in Google Scholar

9 Haaland, A.; Nilsson, J. E.: The determination of the barrier to internal rotation in ferrocene and ruthenocene by means of electron diffraction. Chem. Commun. (1968) 88–89 and references cited therein.10.1039/c19680000088Search in Google Scholar

10 Eberson, L.; Calvert, J. L.; Hartshorn, M. P.; Robinson, W. T.: Photochemical nitration by tetranitromethane. XV. Formation of adducts and their secondary products in the photochemical reaction between benzene and tetranitromethane. Acta Chem. Scand. 48 (1994) 347–355.10.3891/acta.chem.scand.48-0347Search in Google Scholar

11 Maftei, C. V.; Fodor, E.; Jones, P. G.; Franz, M. H.; Kelter, G.; Fiebig, H.; Neda, I.: Synthesis and characterization of novel bioactive 1,2,4-oxadiazole natural product analogs bearing the N-phenylmaleimide and N-phenylsuccinimide moieties. Beil. J. Org. Chem. 9 (2013) 2202–2215.10.3762/bjoc.9.259Search in Google Scholar

12 Wang, P.-L.; Zeng, H.-S.; Wang, H.-B.; Wu, W.-Y.: 5-Chloromethyl-3-(4-methylphenyl)-1,2,4-oxadiazole. Acta Crystallogr. E63 (2007) o4619.10.1107/S1600536807056073Search in Google Scholar

13 Štěpnička, P.; Císařová, I.; Nižňanský, D.; Bakardjieva, S.: The crystal structures, molecular spectra and thermal behaviour of carbamoylferrocene and ferrocenecarbonylhydrazide. Polyhedron 29 (2010) 134–141.10.1016/j.poly.2009.06.034Search in Google Scholar

14 Lin, L.; Berces, A.; Kraatz, H.-B.: Ferrocenic acid derivatives: towards rationalizing changes in the electronic and geometric structures. J. Organomet. Chem. 556 (1998) 11–20.10.1016/S0022-328X(97)00785-7Search in Google Scholar

Received: 2017-1-17
Accepted: 2017-5-13
Published Online: 2017-5-31
Published in Print: 2017-7-26

©2017 Karel Škoch et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Cover and Frontmatter
  2. Crystal structure of poly[diaqua-(μ2-4,4′-bipyridine-κ2N:N′)manganese(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2) C42H40Cl2MnN6O10S2
  3. The crystal structure of 1,2-bis[2-methyl-5-(3-cyanophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluoro-cyclopent-1-ene, C29H16F6N2S2
  4. Crystal structure of the first characterized polymeric copper and sodium complex diaqua-(tris-acetato-κO,O′)(μ2-acetato-κO′′)dinatrium copper(II) monohydrate, C8H18CuNa2O11
  5. The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-3-yl-methylene)aniline, C18H22N2
  6. Crystal structure of methyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C20H22N2O5
  7. Crystal structure of bis(1,3-bis(diphenylphosphino)propane-κ2P,P′)silver(I) trifluorosulfonate–methanol (1:0.5), [Ag(C27H26P2)]SO3CF3⋅0.5CH3OH
  8. Crystal structure of μ-1,4-bis(diphenylphosphine)butane-2,9-dimethyl-1,10-phenanthroline-κ2N:N′-bis(cyano-κC)dicopper(I)]-water, C58H56Cu2N6O2P2
  9. Crystal structure of N2,N6-bis(1-hydrazinyl-2-methyl-1-oxopropan-2-yl) pyridine-2,6-dicarboxamide, C15H23N7O4
  10. Crystal structure of 1,3-dimethyl-2-phenyl-1H-perimidin-3-ium iodide, C19H17IN2
  11. Crystal structure of diaqua-(2,2′-(butane-1,4-diyl)-bis(5-carboxy-1H-imidazole-4-carboxylato)-κ4O,O′,N,N′)cadmium(II) monohydrate, C14H18O11N4Cd
  12. Crystal structure of ethyl (E)-3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl) acrylate, C15H14Cl2FNO3
  13. Crystal structure of bis-(1-(4-chlorophenyl)-3-phenyl-4-thenoyl-1H-pyrazol-5-ol-κ2O,O′)-(N,N-dimethylformamide)zinc(II), C43H31Cl2N5O5S2Zn
  14. Crystal structure of tetrakis(μ3-2-(N-(2-hydroxyethyl)amino)ethoxo)-tetrachloro-tetra-cobalt(II) methanol solvate, C17H44Cl4Co4N4O9
  15. Crystal structure of 3-amino-1-(4-bromophenyl)-9-methoxy-1H-benzo[f]chromene-2-carbonitrile, C21H15BrN2O2
  16. Crystal structure of 2-amino-4-(4-isopropyl-phenyl)-3-cyano-5-oxo-4H,5H-pyrano[3,2-c]chromene, C22H18N2O3
  17. Crystal structure of 3-amino-8-methoxy-1-(4-methoxy phenyl)-1H-benzo[f]chromene-2-carbonitrile, C22H18N2O3
  18. Crystal structure of monoaqua-[6,6′-((1E,1′E)-(1,2-phenylene bis(azanylylidene))bis(methanylylidene))bis(4-bromo-2-nitrophenolato-κ4N,N′,O,O′)]zinc(II), C20H12Br2N4O7Zn
  19. Crystal structure of 11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(prop-1-yn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one – acetonitril (1/2), C33H41N3O2
  20. Crystal structure of tert-butyl (phenylsulfinyl)carbamate, C11H15NO3S
  21. Crystal structure of catena-poly{diaqua-bis(3-(1H-1,2,4-triazol-1-yl)benzoato-κ2O:N)copper(II)} monohydrate, C18H18CuN6O7
  22. Crystal structure of tetraaqua-bis(3-(4H-1,2,4-triazol-4-yl)benzoato-κN)cobalt(II), C18H20CoN6O8
  23. The crystal structure of 4-bromo-N-cyclopropyl-2,5-difluorobenzenesulfonamide, C9H8BrF2NO2S
  24. Crystal structure of ([3,3′-bipyridine]-6,6′-dicarboxylato-κ2O:O′)-bis(1,2-bis(4-pyridyl)ethane-κ2N:N′)disilver(I) dihydrate, C37H35Ag2N5O6
  25. The crystal structure of (4-(1H-1,2,4-triazol-1-yl)benzoato-κN)-[4-(1H-1,2,4-triazol-1-yl)benzoic acid-κN]silver(I), C18H13AgN6O4
  26. Crystal structure of 3-(4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one, C17H16O2
  27. Crystal structure of bis(2-((E)-((4-((E)-1-(ethoxyimino)ethyl)phenyl)imino)methyl)-5-methoxyphenolato-κ2O,N)copper(II), C36H38CuN4O6
  28. Crystal structure of poly[1,2-bis(1,2,4-triazol-4-yl)ethane-κ2N:N′]silver(I) bromate monohydrate]silver(I), C6H10AgBrN6O4
  29. The crystal structure of 2,3,5-triphenyl-2,3-dihydro-1H-tetrazol-1-ium 2,3-dioxoindoline-5-sulfonate, C27H19N5O5S
  30. Crystal structure of 3-(2-amino-1,3-selenazol-4-yl)-2H-chromen-2-one – dimethylformamide (1/1), C15H15N3O3Se
  31. Crystal structure of diethyl 3,3′-(diazene-1,2-diyl)(E)-dibenzoate, C18H18N2O4
  32. Crystal structure of cis-bis((1H-benzimidazol-2-yl)methanol-κN,O)-bis(isothiocyanato-κN)nickel(II), C18H16N6NiO2S2
  33. Crystal structure of bis(2-(2′-hydroxy-5′-methoxyphenyl)-1H-benzimidazole)boron – tetrahydrofuran (1/1), C36H37N4O6B
  34. Crystal structure of poly[aqua-bis(nitrato-κ2O,O′)-(μ3-1,3-benzimidazol-3-ium-1,3-diacetato-κ4O,O′:O′′:O′′′)dysprosium(III)], C11H11DyN4O11
  35. Crystal structure of n-butyl-tris(dicyclo-hexylamido)hafnium(IV), C40H75HfN3
  36. Crystal structure of (E)-1-[1-(3-chloro-4-fluoro-phenyl)ethylidene]-2-(2,4-dinitrophenyl)hydrazine, C28H20Cl2F2N8O8
  37. The crystal structure of ethyl 4-((2-hydroxybenzyl)amino)benzoate, a Schiff base, C16H17NO3
  38. Crystal structure of 3-(2-(4-isobutylphenyl)propanoyl)-1-methylimidazolidine-2,4-dione, C17H22N2O3
  39. Crystal structure of poly[(μ3-2-(pyrazin-2-ylthio)acetato-κ3N:O:S)silver(I)], C6H5AgN2O2S
  40. Crystal structure of (E)-1-(3-((E)-((2-hydroxynaphthalen-1-yl)methylene)amino)phenyl)ethanone O-benzyl oxime, C26H22N2O2
  41. Crystal structure of (E)-2,3-dihydroxybenzaldehyde O-(2-((((E)-1-(2,5-dihydroxyphenyl)ethylidene)amino)oxy)ethyl) oxime monohydrate, C17H20N2O7
  42. Crystal structure of 4-(chloromethyl)-3-nitrobenzoic acid, C8H6ClNO4
  43. Crystal stucture of 4-((10H-phenothiazin-10-yl)methyl)-2,6-di-tert-butylphenol, C27H31NOS
  44. The crystal structure of ethyl 1-(4-nitrophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate, C13H10F3N3O4
  45. Crystal structure of catena-poly[di-(μ3-oxido-κ3O:O:O)-tetraoxido-(μ2-5′-(pyrazin-2-yl)-1H,2′H-3,3′-bi(1,2,4-triazole)-κ2N:N′)dimolybdenum(VI)], C8H6Mo2N8O6
  46. Crystal structure of (3,6-dioxocyclohexa-1,4-diene-1,4-bis(olato)-κ4O,O′:O′′,O′′′)-bis(tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′))-dizinc(II) bis(hexafluorophosphate(V)), C42H38F12N8O4P2Zn2
  47. Crystal structure of catena-poly[hexakis(μ2-2-acetylphenolato-κ3O:O,O′)trimanganese(II)], C48H42Mn3O12
  48. The crystal structure of 2,2-difluoro-4-(trifluoromethyl)-2,5-dihydro-[1,3,2]dioxaborinino[5,4-c]chromen-3-ium-2-uide, C11H6BF5O3
  49. Crystal structure of methyl (E)-2-(4-(diethylamino)-2-hydroxybenzylidene)hydrazine-1-carboxylate, C13H19N3O3
  50. The crystal structure of tert-butyl 2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylate, C10H15N3O2
  51. Crystal structure of 1,1-bis(η5-adamantylcyclopentadienyl)-3-phenyl-2-trimethylsilyl-2,3-dihydroisotitanazole, C42H55NSiTi
  52. Crystal structure of 2-(4-(2-(4-benzylpiperazin-1-yl)ethyl)benzyl)isoindoline-1,3-dione, C28H29N3O2
  53. Important impurity of Flupirtine – a single crystal study on ethyl (6-amino-5-((ethoxycarbonyl)amino)pyridin-2-yl)(4-fluorobenzyl)carbamate, C18H21FN4O4
  54. Crystal structure of ethyl 3-(4-methoxyphenyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-pyrazole-5-carboxylate, C22H22N2O5
  55. Crystal structure of 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium 5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate methanol solvate, C37H35N1O10
  56. The crystal structure of the inner salt of 2-[(aminoiminomethyl)amino]ethylcarbamic acid [systematic name: (2-((diaminomethylene)ammonio)ethyl)carbamate], C4H10N4O2
  57. Crystal structure of (8-hydroxy-5-nitroquinolinium) perchlorate – 8-hydroxy-5-nitroquinoline (1/1), C18H13ClN4O10
  58. The crystal structure of (5-methyl-1,2,4-oxadiazol-3-yl)ferrocene, C13H12FeN2O
  59. Crystal structure of methyl 1-(2-(fluorosulfonyl)ethyl)-2-oxocyclopentanecarboxylate, C9H13FO5S
  60. Crystal structure of the triclinic modification of 1-methyl-4-nitroimidzole, C4H5N3O2
  61. Corrigendum
  62. Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O
https://doi.org/10.1515/ncrs-2017-0015
Creative Commons
BY-NC-ND 3.0

Articles in the same Issue

  1. Cover and Frontmatter
  2. Crystal structure of poly[diaqua-(μ2-4,4′-bipyridine-κ2N:N′)manganese(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2) C42H40Cl2MnN6O10S2
  3. The crystal structure of 1,2-bis[2-methyl-5-(3-cyanophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluoro-cyclopent-1-ene, C29H16F6N2S2
  4. Crystal structure of the first characterized polymeric copper and sodium complex diaqua-(tris-acetato-κO,O′)(μ2-acetato-κO′′)dinatrium copper(II) monohydrate, C8H18CuNa2O11
  5. The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-3-yl-methylene)aniline, C18H22N2
  6. Crystal structure of methyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C20H22N2O5
  7. Crystal structure of bis(1,3-bis(diphenylphosphino)propane-κ2P,P′)silver(I) trifluorosulfonate–methanol (1:0.5), [Ag(C27H26P2)]SO3CF3⋅0.5CH3OH
  8. Crystal structure of μ-1,4-bis(diphenylphosphine)butane-2,9-dimethyl-1,10-phenanthroline-κ2N:N′-bis(cyano-κC)dicopper(I)]-water, C58H56Cu2N6O2P2
  9. Crystal structure of N2,N6-bis(1-hydrazinyl-2-methyl-1-oxopropan-2-yl) pyridine-2,6-dicarboxamide, C15H23N7O4
  10. Crystal structure of 1,3-dimethyl-2-phenyl-1H-perimidin-3-ium iodide, C19H17IN2
  11. Crystal structure of diaqua-(2,2′-(butane-1,4-diyl)-bis(5-carboxy-1H-imidazole-4-carboxylato)-κ4O,O′,N,N′)cadmium(II) monohydrate, C14H18O11N4Cd
  12. Crystal structure of ethyl (E)-3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl) acrylate, C15H14Cl2FNO3
  13. Crystal structure of bis-(1-(4-chlorophenyl)-3-phenyl-4-thenoyl-1H-pyrazol-5-ol-κ2O,O′)-(N,N-dimethylformamide)zinc(II), C43H31Cl2N5O5S2Zn
  14. Crystal structure of tetrakis(μ3-2-(N-(2-hydroxyethyl)amino)ethoxo)-tetrachloro-tetra-cobalt(II) methanol solvate, C17H44Cl4Co4N4O9
  15. Crystal structure of 3-amino-1-(4-bromophenyl)-9-methoxy-1H-benzo[f]chromene-2-carbonitrile, C21H15BrN2O2
  16. Crystal structure of 2-amino-4-(4-isopropyl-phenyl)-3-cyano-5-oxo-4H,5H-pyrano[3,2-c]chromene, C22H18N2O3
  17. Crystal structure of 3-amino-8-methoxy-1-(4-methoxy phenyl)-1H-benzo[f]chromene-2-carbonitrile, C22H18N2O3
  18. Crystal structure of monoaqua-[6,6′-((1E,1′E)-(1,2-phenylene bis(azanylylidene))bis(methanylylidene))bis(4-bromo-2-nitrophenolato-κ4N,N′,O,O′)]zinc(II), C20H12Br2N4O7Zn
  19. Crystal structure of 11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(prop-1-yn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one – acetonitril (1/2), C33H41N3O2
  20. Crystal structure of tert-butyl (phenylsulfinyl)carbamate, C11H15NO3S
  21. Crystal structure of catena-poly{diaqua-bis(3-(1H-1,2,4-triazol-1-yl)benzoato-κ2O:N)copper(II)} monohydrate, C18H18CuN6O7
  22. Crystal structure of tetraaqua-bis(3-(4H-1,2,4-triazol-4-yl)benzoato-κN)cobalt(II), C18H20CoN6O8
  23. The crystal structure of 4-bromo-N-cyclopropyl-2,5-difluorobenzenesulfonamide, C9H8BrF2NO2S
  24. Crystal structure of ([3,3′-bipyridine]-6,6′-dicarboxylato-κ2O:O′)-bis(1,2-bis(4-pyridyl)ethane-κ2N:N′)disilver(I) dihydrate, C37H35Ag2N5O6
  25. The crystal structure of (4-(1H-1,2,4-triazol-1-yl)benzoato-κN)-[4-(1H-1,2,4-triazol-1-yl)benzoic acid-κN]silver(I), C18H13AgN6O4
  26. Crystal structure of 3-(4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one, C17H16O2
  27. Crystal structure of bis(2-((E)-((4-((E)-1-(ethoxyimino)ethyl)phenyl)imino)methyl)-5-methoxyphenolato-κ2O,N)copper(II), C36H38CuN4O6
  28. Crystal structure of poly[1,2-bis(1,2,4-triazol-4-yl)ethane-κ2N:N′]silver(I) bromate monohydrate]silver(I), C6H10AgBrN6O4
  29. The crystal structure of 2,3,5-triphenyl-2,3-dihydro-1H-tetrazol-1-ium 2,3-dioxoindoline-5-sulfonate, C27H19N5O5S
  30. Crystal structure of 3-(2-amino-1,3-selenazol-4-yl)-2H-chromen-2-one – dimethylformamide (1/1), C15H15N3O3Se
  31. Crystal structure of diethyl 3,3′-(diazene-1,2-diyl)(E)-dibenzoate, C18H18N2O4
  32. Crystal structure of cis-bis((1H-benzimidazol-2-yl)methanol-κN,O)-bis(isothiocyanato-κN)nickel(II), C18H16N6NiO2S2
  33. Crystal structure of bis(2-(2′-hydroxy-5′-methoxyphenyl)-1H-benzimidazole)boron – tetrahydrofuran (1/1), C36H37N4O6B
  34. Crystal structure of poly[aqua-bis(nitrato-κ2O,O′)-(μ3-1,3-benzimidazol-3-ium-1,3-diacetato-κ4O,O′:O′′:O′′′)dysprosium(III)], C11H11DyN4O11
  35. Crystal structure of n-butyl-tris(dicyclo-hexylamido)hafnium(IV), C40H75HfN3
  36. Crystal structure of (E)-1-[1-(3-chloro-4-fluoro-phenyl)ethylidene]-2-(2,4-dinitrophenyl)hydrazine, C28H20Cl2F2N8O8
  37. The crystal structure of ethyl 4-((2-hydroxybenzyl)amino)benzoate, a Schiff base, C16H17NO3
  38. Crystal structure of 3-(2-(4-isobutylphenyl)propanoyl)-1-methylimidazolidine-2,4-dione, C17H22N2O3
  39. Crystal structure of poly[(μ3-2-(pyrazin-2-ylthio)acetato-κ3N:O:S)silver(I)], C6H5AgN2O2S
  40. Crystal structure of (E)-1-(3-((E)-((2-hydroxynaphthalen-1-yl)methylene)amino)phenyl)ethanone O-benzyl oxime, C26H22N2O2
  41. Crystal structure of (E)-2,3-dihydroxybenzaldehyde O-(2-((((E)-1-(2,5-dihydroxyphenyl)ethylidene)amino)oxy)ethyl) oxime monohydrate, C17H20N2O7
  42. Crystal structure of 4-(chloromethyl)-3-nitrobenzoic acid, C8H6ClNO4
  43. Crystal stucture of 4-((10H-phenothiazin-10-yl)methyl)-2,6-di-tert-butylphenol, C27H31NOS
  44. The crystal structure of ethyl 1-(4-nitrophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate, C13H10F3N3O4
  45. Crystal structure of catena-poly[di-(μ3-oxido-κ3O:O:O)-tetraoxido-(μ2-5′-(pyrazin-2-yl)-1H,2′H-3,3′-bi(1,2,4-triazole)-κ2N:N′)dimolybdenum(VI)], C8H6Mo2N8O6
  46. Crystal structure of (3,6-dioxocyclohexa-1,4-diene-1,4-bis(olato)-κ4O,O′:O′′,O′′′)-bis(tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′))-dizinc(II) bis(hexafluorophosphate(V)), C42H38F12N8O4P2Zn2
  47. Crystal structure of catena-poly[hexakis(μ2-2-acetylphenolato-κ3O:O,O′)trimanganese(II)], C48H42Mn3O12
  48. The crystal structure of 2,2-difluoro-4-(trifluoromethyl)-2,5-dihydro-[1,3,2]dioxaborinino[5,4-c]chromen-3-ium-2-uide, C11H6BF5O3
  49. Crystal structure of methyl (E)-2-(4-(diethylamino)-2-hydroxybenzylidene)hydrazine-1-carboxylate, C13H19N3O3
  50. The crystal structure of tert-butyl 2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylate, C10H15N3O2
  51. Crystal structure of 1,1-bis(η5-adamantylcyclopentadienyl)-3-phenyl-2-trimethylsilyl-2,3-dihydroisotitanazole, C42H55NSiTi
  52. Crystal structure of 2-(4-(2-(4-benzylpiperazin-1-yl)ethyl)benzyl)isoindoline-1,3-dione, C28H29N3O2
  53. Important impurity of Flupirtine – a single crystal study on ethyl (6-amino-5-((ethoxycarbonyl)amino)pyridin-2-yl)(4-fluorobenzyl)carbamate, C18H21FN4O4
  54. Crystal structure of ethyl 3-(4-methoxyphenyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-pyrazole-5-carboxylate, C22H22N2O5
  55. Crystal structure of 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium 5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate methanol solvate, C37H35N1O10
  56. The crystal structure of the inner salt of 2-[(aminoiminomethyl)amino]ethylcarbamic acid [systematic name: (2-((diaminomethylene)ammonio)ethyl)carbamate], C4H10N4O2
  57. Crystal structure of (8-hydroxy-5-nitroquinolinium) perchlorate – 8-hydroxy-5-nitroquinoline (1/1), C18H13ClN4O10
  58. The crystal structure of (5-methyl-1,2,4-oxadiazol-3-yl)ferrocene, C13H12FeN2O
  59. Crystal structure of methyl 1-(2-(fluorosulfonyl)ethyl)-2-oxocyclopentanecarboxylate, C9H13FO5S
  60. Crystal structure of the triclinic modification of 1-methyl-4-nitroimidzole, C4H5N3O2
  61. Corrigendum
  62. Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 19.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2017-0015/html?srsltid=AfmBOorN0keYQNMnFngYwS1tp9RoxCXQpL7SrKcbK1-zuAPs2Sw8gYJq
Scroll to top button